This trio of insurers is leading the bull market and should do even better as interest rates rise. Read More
Archive
Filter
This company's cutting-edge research into stem cells promises to make aggressive cancers more treatable. Read More
Our first-quarter Growth returns once again show that balance and patience win the race. Read More
First-quarter results vindicate the investment philosophy behind our Income Portfolio. Read More
Downside protection remains our mantra in this volatile market. Read More
Article in Review: "The Cream of the Wheat Handlers," by David Dittman, April 11, 2012. Read More
Investment clubs are a great way to make friends and profits. Here’s a guide to successful club membership. Read More
Conditions aren’t yet in place for natural resources and other commodities to fall prey to the bear. Read More
Apple (NSDQ: AAPL) for the last decade has been a darling of customers and investors. Now, it’s in the doghouse—despite its considerable future prospects. From our contrarian perspective, that’s the time to buy a stock. In fact, our faith in Apple is so strong, we’re adding it to the Growth… Read More
Alarmist headlines about the US job market haven’t shaken our long-term confidence in our game plan. Quality, diversification and balance will win the day. Read More